Article Details
Retrieved on: 2021-08-18 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On August 18, 2021 , AzurRx BioPharma, Inc. issued a press release announcing positive topline data for its Phase 2 clinical trial of MS1819 in ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here